{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:30:33Z","timestamp":1787506233700,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2825-7","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T22:30:23Z","timestamp":1511217023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates"],"prefix":"10.1186","volume":"17","author":[{"given":"Parisa","family":"Badiee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Badali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun","family":"Boekhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Diba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolkarim Ghadimi","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hossaini Nasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadis","family":"Jafarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Mirhendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Shamsizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"2825_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.riam.2013.10.001","volume":"31","author":"G Quind\u00f3s","year":"2014","unstructured":"Quind\u00f3s G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol. 2014;31:42\u20138.","journal-title":"Rev Iberoam Micol"},{"key":"2825_CR2","first-page":"381","volume":"14","author":"P Badiee","year":"2011","unstructured":"Badiee P, Alborzi A. Assessment of real-time PCR method to detect human non-Cryptococcal fungal meningitis. Arch Iran Med. 2011;14:381\u20134.","journal-title":"Arch Iran Med"},{"key":"2825_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/0255-0857.83920","volume":"29","author":"R Adhikary","year":"2011","unstructured":"Adhikary R, Joshi S. Species distribution and anti-fungal susceptibility of Candidaemia at a multi super-specialty center in southern India. Indian J Med Microbiol. 2011;29:309.","journal-title":"Indian J Med Microbiol"},{"key":"2825_CR4","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","volume":"44","author":"AL Colombo","year":"2006","unstructured":"Colombo AL, Nucci M, Park BJ, Nou\u00e9r SA, Arthington-Skaggs B, da Matta DA, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44:2816\u201323.","journal-title":"J Clin Microbiol"},{"key":"2825_CR5","unstructured":"Wayne P. Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Fourth Informational Supplement. CLSI document. 2012; M27-S4."},{"key":"2825_CR6","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida species. By use of clinical and laboratory standards institute broth microdilution methods, 2010 to 2012. J Clin Microbiol. 2012;50:2846\u201356.","journal-title":"J Clin Microbiol"},{"key":"2825_CR7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of cancer\/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases mycoses study group EORTC\/MSG consensus group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"2825_CR8","unstructured":"Wayne P. Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document 2008; M27-A3."},{"key":"2825_CR9","doi-asserted-by":"crossref","first-page":"e36952","DOI":"10.1371\/journal.pone.0036952","volume":"7","author":"B W\u00e4chtler","year":"2012","unstructured":"W\u00e4chtler B, Citiulo F, Jablonowski N, F\u00f6rster S, Dalle F, Schaller M, et al. Candida albicans epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process. PLoS One. 2012;7:e36952.","journal-title":"PLoS One"},{"key":"2825_CR10","doi-asserted-by":"crossref","first-page":"e0118770","DOI":"10.1371\/journal.pone.0118770","volume":"10","author":"EJ Won","year":"2015","unstructured":"Won EJ, Shin JH, Choi MJ, Lee WG, Park YJ, Uh Y, et al. Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage. PLoS One. 2015;10:e0118770.","journal-title":"PLoS One"},{"key":"2825_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.26719\/2011.17.5.425","volume":"17","author":"P Badiee","year":"2011","unstructured":"Badiee P, Alborzi A, Shakiba E, Farshad S, Japoni A. Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents. East Mediterr Health J. 2011;17:425.","journal-title":"East Mediterr Health J"},{"key":"2825_CR12","first-page":"177","volume":"Special Issue 1","author":"PA Khan","year":"2015","unstructured":"Khan PA, Fatima N, Nabeela S, Khan HM, Malik A. Antifungal susceptibility pattern of Candida isolates from a tertiary care hospital in north India: a five-year study. Int J Curr Microbiol App Sci. 2015;Special Issue 1:177\u201381.","journal-title":"Int J Curr Microbiol App Sci"},{"key":"2825_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11046-014-9772-2","volume":"178","author":"M Castanheira","year":"2012","unstructured":"Castanheira M, Messer SA, Rhomberg PR, Dietrich RR, Jones RN, Pfaller MA. Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values. Mycopathologia. 2012;178:1\u20139.","journal-title":"Mycopathologia"},{"key":"2825_CR14","first-page":"e11858","volume":"7","author":"P Haddadi","year":"2014","unstructured":"Haddadi P, Zareifar S, Badiee P, Alborzi A, Mokhtari M, Zomorodian K, et al. Yeast colonization and drug susceptibility pattern in the pediatric patients with neutropenia. Jundishapur J Microbiol. 2014;7:e11858.","journal-title":"Jundishapur J Microbiol"},{"key":"2825_CR15","doi-asserted-by":"crossref","unstructured":"Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Moulds: Application of CLSI Epidemiological Cutoff Values and Whole Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans. Antimicrob Agents Chemother . 2017:AAC-00906.","DOI":"10.1128\/AAC.00906-17"},{"issue":"4","key":"2825_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diagmicrobio.2015.04.008","volume":"82","author":"MA Pfaller","year":"2015","unstructured":"Pfaller MA, Rhomberg PR, Messer SA, Jones RN, Castanheira M. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values. Diagn Microbiol Infect Dis. 2015;82(4):303\u201313.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"2825_CR17","first-page":"391","volume":"11","author":"P Badiee","year":"2009","unstructured":"Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Rasuli M. Molecular identification and in-vitro susceptibility of Candida albicans and Candida dubliniensis isolated from immunocompromised patients. Iran Red Crescent Med J. 2009;11(4):391\u20137.","journal-title":"Iran Red Crescent Med J"},{"key":"2825_CR18","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/AAC.01757-10","volume":"55","author":"M Cuenca-Estrella","year":"2011","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Cuesta I, Zaragoza O, Mellado E, Rodriguez-Tudela JL. Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida species. According to breakpoints established by the antifungal Subcommittee of the European Committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother. 2011;55:1794\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2825_CR19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1439-0507.2007.01356.x","volume":"50","author":"G Soczo","year":"2007","unstructured":"Soczo G, Kardos G, McNicholas PM, Falusi E, Gergely L, Majoros L. Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods. Mycoses. 2007;50:178\u201382.","journal-title":"Mycoses"},{"key":"2825_CR20","first-page":"e24298","volume":"8","author":"AZ Mahmoudabadi","year":"2015","unstructured":"Mahmoudabadi AZ, Rezaei-Matehkolaei A, Ghanavati F. The susceptibility patterns of Candida species isolated from urine samples to posaconazole and caspofungin. Jundishapur J Microbiol. 2015;8:e24298.","journal-title":"Jundishapur J Microbiol"},{"key":"2825_CR21","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/AAC.00148-06","volume":"50","author":"M Hakki","year":"2006","unstructured":"Hakki M, Staab JF, Marr KA. Emergence of a Candida krusei isolates with reduced susceptibility to caspofungin during therapy. Antimicrob Agents Chemother. 2006;50:2522\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"2825_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-015-0442-4","volume":"15","author":"MT Montagna","year":"2015","unstructured":"Montagna MT, Lovero G, Coretti C, Martinelli D, De Giglio O, Iatta R, et al. Susceptibility to echinocandins of Candida species strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. BMC Microbiol. 2015;15:1.","journal-title":"BMC Microbiol"},{"key":"2825_CR23","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","volume":"57","author":"A Espinel-Ingroff","year":"2013","unstructured":"Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, et al. Inter laboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother. 2013;57:5836\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"2825_CR24","first-page":"e18353","volume":"l8","author":"H Shekari Ebrahim Abad","year":"2015","unstructured":"Shekari Ebrahim Abad H, Zaini F, Kordbacheh P, Mahmoudi M, Safara M, Mortezaee V. In vitro activity of caspofungin against fluconazole-resistant Candida species isolated from clinical samples in Iran. Jundishapur J Microbio. 2015;l8:e18353.","journal-title":"Jundishapur J Microbio"},{"key":"2825_CR25","doi-asserted-by":"crossref","unstructured":"Jensen RH, Johansen HK, S\u00f8es LM, Lemming LE, Rosenvinge FS, Nielsen L, et al. Post treatment antifungal Resistance among colonizing Candida isolates in candidemia patients: Results from a systematic multicenter study. Antimicrob Agents Chemother . 2015; 28; 60(3):1500-8.","DOI":"10.1128\/AAC.01763-15"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T07:10:19Z","timestamp":1570345819000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2825-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2825"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2825-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"article-number":"727"}}